Listed

Bruker Corp

BRKRNasdaqCIK 1109354TechnologyFiscal year ends Dec 31

Reports and events: 309 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Bruker Corp, Reports and events
FiledFormWhat it isAccession number
2024-04-2207:16 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-049697
2024-04-1916:34 ETDEF 14AProxy statementPeriod 2024-05-300000950170-24-046045
2024-04-0209:28 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-24-039776
2024-02-2915:58 ET10-KAnnual reportPeriod 2023-12-310000950170-24-023038
2024-02-1307:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-014189
2024-02-1207:02 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-24-013561
2024-02-0216:38 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-24-010557
2024-01-1920:29 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-24-005565
2024-01-0812:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0000950170-24-002823
2023-12-2609:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure0000950170-23-072832
2023-11-0916:54 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-062192
2023-11-0207:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-057737
2023-08-0915:27 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-040491
2023-08-0307:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-037567
2023-06-0717:16 ET8-K5.07 Shareholder vote results0000950170-23-026851
2023-05-1516:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-022180
2023-05-1015:10 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-020404
2023-05-0407:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-017460
2023-04-2816:19 ETDEF 14AProxy statement0000950170-23-015837
2023-03-0118:20 ET10-KAnnual reportPeriod 2022-12-310000950170-23-005251
2023-02-2107:00 ET8-K8.01 Other events0000950170-23-003292
2023-02-0907:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-002241
2023-01-0911:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0000950170-23-000482
2022-11-0415:11 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-022163
2022-11-0307:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-021537
2022-08-0515:12 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-015090
2022-08-0316:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-014277
2022-06-0116:20 ET8-K5.07 Shareholder vote results0001193125-22-165198
2022-05-0614:05 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008094
2022-05-0407:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-007184
2022-04-2216:01 ETDEF 14AProxy statementPeriod 2022-06-010001193125-22-115070
2022-03-1609:55 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-076869
2022-02-2810:46 ET10-KAnnual reportPeriod 2021-12-310001193125-22-056531
2022-02-1107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-035665
2022-01-1007:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0001193125-22-005065
2021-12-0807:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-21-350814
2021-11-0516:01 ET10-QQuarterly reportPeriod 2021-09-300001193125-21-321572
2021-11-0116:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-315384
2021-08-2016:16 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-252755
2021-08-0509:14 ET10-QQuarterly reportPeriod 2021-06-300001193125-21-237150
2021-08-0216:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-233233
2021-06-1708:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-192728
2021-06-0716:05 ET8-K5.07 Shareholder vote results0001193125-21-184282
2021-06-0207:00 ET8-K7.01 Regulation FD disclosure0001193125-21-179208
2021-05-1308:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-159866
2021-05-1018:31 ET10-QQuarterly reportPeriod 2021-03-310001193125-21-155172
2021-05-0507:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-150744
2021-04-2016:31 ETDEF 14AProxy statementPeriod 2021-06-040001193125-21-122904
2021-04-1316:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-114712
2021-03-0115:37 ET10-KAnnual reportPeriod 2020-12-310001104659-21-029938

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 16:58 ET. Listed shows no prices and gives no investment advice.